ÃÑ ¹æ¹®ÀÚ¼ö
367,602,028
Ȩ ·Î ±× ÀΠȸ ¿ø °¡ ÀÔ ÀÚÀ¯°Ô½ÃÆÇ ºÎÃß¿¬ ¼Ò°³ ã¾Æ¿À½Ã´Â ±æ
¾îÁ¦ÀÇ ¹æ¹®ÀÚ¼ö
3,372

¿À´ÃÀÇ ¹æ¹®ÀÚ¼ö
1,486

     ÈÄ    ¿ø    ±Ý
  ºÎ Ãß ¿¬ ¼º ¸í ¼­
ºÎÃß¿¬TV µ¿¿µ»ó
  ¿À´ÃÀÇ ºÎÁ¤ºÎÆÐ
ÇÖ   ÀÌ   ½´
Á¤ Ã¥ Á¦ ¾È
¾îÁ¦ µé¾î¿Â Á¦º¸
  °ø   Áö    »ç   Ç×
  ¹® Àç ÀÎ ºñ ¸®
  ±è Á¤ Àº ºñ ¸®
  ºÏ ±« ºñ ¸®
  ±¹ ȸ ÀÇ ¿ø ºñ ¸®
  °ø Á÷ ÀÚ ºñ ¸®
  °Ë Âû °æ Âû ºñ¸®
  ÆÇ »ç ºñ ¸®
  º¯ È£ »ç ºñ ¸®
  ¾ð ·Ð ºñ ¸®
  ±º ´ë ºñ ¸®
  ³ó ¾î ÃÌ ºñ ¸®
  ±³ À° ºñ ¸®
  ±â ¾÷ ºñ ¸®
  ¼¼ ¹« ºñ ¸®
  °Ç ¼³ ±³ Åë ºñ¸®
  ±Ý À¶ º¸ Çè ºñ¸®
  Á¤ º¸ Åë ½Å ºñ¸®
  Á¾ ±³ ºñ ¸®
À¥Èıâ
 
 
ÀÛ¼ºÀÚ : ¼º±Ý    ÀÛ¼ºÀÏ : 06-01-09 Á¶È¸¼ö : 725 Ãßõ¼ö : 1 ¹øÈ£ :153,659
¿©·Ð 1¹øÁö Ȳ±³¼ö»ç°ÇÀÇ ¹è°æ¿¡ ´ëÇÏ·Á ºÎÃß¿¬
±× ¹èÈÄ¿¡´Â Áß±¹ Áß¾ÓÁ¤º¸ºÎÀÇ À½¸ð°¡ÀÖ´Ù



------------------------------------------------
Áö±Ý ¹Ì±¹¿¡¼­ ¹«½¼ÀÏÀÌ ¹ú¾îÁö°í ÀÖ´ÂÁö ¾Æ½Ã´ÂÁö¿ä?
¹Ì±¹ Life News Áö º¸µµ³»¿ëÀ» Àо¸é »õưÀÌ È²±³¼ö°¡ ±ÃÁö¿¡ ¸ô¸° Æ´À» Ÿ¼­
Ȳ±³¼öÀÇ Áٱ⼼Æ÷ ƯÇã±ÇÀ» Â÷ÁöÇÏ·Á°í Çϰí ÀÖ½À´Ï´Ù. Ãæ°ÝÀûÀÎ Life News ÁöÀÇ
¿ø¹®À» Åä´ë·Î ÀÛ¼ºÇÑ ±ÛÀÔ´Ï´Ù.
À̰ÍÀ» ÀÐÀ¸½Å ÈÄ, ¾Æ·¡ ¿ø¹®À» Àо¼¼¿ä.


Ȳ¿ì¼® ¹Ú»ç°¡ ¹Ì±¹¿¡ ½ÅÃ»ÇØ³õÀº Áٱ⼼Æ÷ ¼¼°è ƯÇã±ÇÀ» »õưÀÌ °¡·Îä·Á
Çϰí ÀÖ½À´Ï´Ù. Ȳ±³¼ö°¡ ¹Ì±¹¿¡ ½ÅûÇÑ Áٱ⼼Æ÷ ±¹Á¦ ƯÇã±Ç¿¡´Â »õư
À̸§ÀÌ µé¾îÀÖÁöµµ ¾Ê¾Ò´Âµ¥ Ȳ±³¼ö°¡ MBC PD¼öø°ú ¼­¿ï´ë Á¶»çÀ§¿øÈ¸¿¡ ¹ß¸ñÀÌ
ÀâÇô Áٱ⼼Æ÷°¡ ¾ø´Ù´Â ¹ßÇ¥°¡ ³ª°¡ÀÚ »õưÀÌ ¹Ù·Î ÀÌ ¶§´Ù¸ç Ȳ±³¼öÇÑÅ×
¾î±ú³Ê¸Ó·Î ¹è¿î Áٱ⼼Æ÷ ¹è¾ç±â¼úÀ» °¡Áö°í Ȳ±³¼ö¸¦ Á¦Ãijõ°í ÀڱⰡ
±¹Á¦Æ¯Ç㸦 ¹Þ±â À§ÇÏ¿© ÆÈÀ» °È°í ³ª¼¹½À´Ï´Ù.
¹Ì±¹ ƯÇãûÀº Ȳ±³¼ö°¡ »çÀ̾ð½ºÁö¿¡ Áٱ⼼Æ÷ÀÇ Ã¢½ÃÀÚ·Î ÀÎÁ¤À» ¹Þ¾Ò°í
Àü¼¼°èÀûÀ¸·Î ÀÎÁ¤À» ¹Þ°í Àֱ⶧¹®¿¡ Ȳ±³¼ö¿¡°Ô ¼¼°è ƯÇã±ÇÀ» ÁÖ·Á°í Çϰí
ÀÖ¾ú´Âµ¥ PD¼öø, ³ë¼ºÀÏ ¿øÀå, ¼­¿ï´ëÁ¶»çÀ§¿øÈ¸°¡ Áٱ⼼Æ÷°¡ ¾ø´Ù´Â ûõº´·Â
°°Àº ¹ßÇ¥¸¦ ÇÏÀÚ »õưÀÌ ÈûÀ» ¾ò°í Ȳ±³¼ö°¡ ¹Ì±¹ ƯÇãû¿¡ Á¦ÃâÇÑ Æ¯ÇãÃâ¿ø ¼­·ù¿¡
¹®Á¦¸¦ Á¦±âÇϰí Àڱ⿡°Ô ƯÇã±ÇÀ» ÁÖ¾î¾ß ÇÑ´Ù°í ÁÖÀåÇÏ°í ³ª¼± °ÍÀÔ´Ï´Ù.
Áٱ⼼Æ÷ ±¹Á¦ ƯÇ㸦 ÃëµæÇÏ¸é ¾ÕÀ¸·Î 100³â°£Àº ´©±¸µµ ¼ÕÀ» ´î ¼ö°¡ ¾ø°í
Çѱ¹Àº Áٱ⼼Æ÷ ±â¼ú Çϳª ¸¸À¸·Î ¸Å³â 350Á¶¿øX100³â=35,000,000,000,000,000¿øÀ»
¹ú¾îµéÀÏ ¼ö°¡ ÀÖ¾ú´Âµ¥ MBC, ³ë¼ºÀÏ, ¼­¿ï´ëÁ¶»çÀ§¿¡ ÀÇÇÏ¿© ¹«»êµÉ À§±â¿¡ ³õÀ̰Ô
µÇ¾ú½À´Ï´Ù.
³í¹®Àº ´©±¸³ª Á¶±Ý¾¿Àº Á¶ÀÛÇÏ´Â °ÍÀ̰í ÀÌ¹Ì Àü¼¼°èÀûÀ¸·Î ±ÇÀ§°¡ ÀÎÁ¤ÀÌ µÈ
Ȳ±³¼ö¸¦ Ȳõ±æ·Î ²ø¾î³»·Á ±¹Á¦Æ¯Çãµµ ¹«»êµÉ À§±â·Î ¸ô°í°£ MBC PD¼öøÀº
´©±º°¡·ÎºÎÅÍ ¾öû³­ µ·À» ¹Þ°í ÀÌ·± ²ûÂïÇÑ ÀÏÀ» ÀúÁú·¶À» °ÍÀÔ´Ï´Ù.
»ï¼ºÀÌ ÀÌ·èÇÑ ¹ÝµµÃ¼ ÀÌÀͱÝÀÇ 100¹è¸¦ ´É°¡ÇÏ´Â »ó»óÀ» ÃÊ¿ùÇÏ´Â ±¹°¡À̵æÀ»
¼ÛµÎ¸®Â° ¾Ñ¾Æ°¡´Â ÁþÀ» ÇÒ Á¤µµ¸é Å« µ·À» ¸ÔÁö¾Ê°í´Â ÇÒ ¼ö¾ø´Â ÁþÀÔ´Ï´Ù.
Ȳ±³¼ö°¡ PD¼öø, ³ë¼ºÀÏ, ¼­¿ï´ë Á¶»çÀ§°¡ ÃijõÀº ÁÖ°ËÀÇ µ£¿¡¼­ Ç®·Á³ª¿Í
Áٱ⼼Æ÷ ¿¬±¸¸¦ °è¼ÓÇÏ¿© ¼¼°èÃÖÃÊ·Î Áٱ⼼Æ÷¸¦ °³¹ßÇÑ´Ù°í ÇÏ´õ¶ó·Î ±¹Á¦Æ¯Çã´Â
ÃëµæÇÒ ¼ö ¾ø°Ô µÅ¹ö·È½À´Ï´Ù. ±¹Á¦Æ¯Çã´Â ÀÌ¹Ì »õưÀ̳ª ´Ù¸¥ »ç¶÷ ¼ÕÀ¸·Î ³Ñ¾î°¥Áö
¸ð¸£¹Ç·Î ±×·¸°Ô µÇ¸é ±¹Á¦Æ¯Çã±ÇÀ» °¡Áø »ç¶÷¿¡°Ô ºÎǰÀ» ³³Ç°ÇÏ´Â ½ÄÀ¸·Î ±â¼ú
Á¦°øÀ» ÇÏ´Â ¼öÁعۿ¡´Â ¾ÈµÉ °ÍÀÔ´Ï´Ù.
MBC-PD¼öøÀÌ ¾ó¸¶³ª ¸Å±¹³ëÁþÀ» ÀúÁú·¶½À´Ï±î? PD¼öøÀº ¾Æ¸¶µµ ³ë¼ºÀÏ ÃøÀÇ
»çÁÖ¸¦ ¹Þ°í ÀÌ·± ÁþÀ» ÇÏ¿´À» °ÍÀÔ´Ï´Ù. ³ë¼ºÀÏÀº Ȳ±³¼ö¸¦ °Å²Ù·¯Æ®·Á¾ß
»õư°ú ¼ÕÀâ°í ¼ö Á¶¿øÀ» ¹ú¾îµéÀÏ ¼ö ÀÖ´Â Áٱ⼼Æ÷ Àå»ç¸¦ ÇÒ ¼öÀÖ¾ú±â ¶§¹®¿¡
ÀÌ·± ²ûÂïÇÑ ÁþÀ» ÀúÁö¸£Áö ¾Ê¾ÒÀ»±î¿ä?
¼ö Á¶¿øÀÌ ´«¾Õ¿¡ ¾Æ¸¥°Å¸®´Ï »ç¶÷µéÀ» ¸Å¼öÇÏ´Â µ¥ ¾öû³­ µ·À» »Ñ·ÈÀ» °ÍÀÔ´Ï´Ù.
PD¼öøµµ ±× ÁßÀÇ ÇϳªÀϲ¨±¸¿ä...


¹Ì ¶óÀÌÇÁ´º½º»ç°¡ ¿À´ÃÀÚ(ÇöÁö½Ã°£)·Î ¿Ã¸° ÀÎÅÍ³Ý ±â»çÀÔ´Ï´Ù.

Former Hwang Partner Wants to Patent Human Cloning Process
by Steven Ertelt
LifeNews.com Editor
January 7, 2006


Pittsburgh, PA (LifeNews.com) -- A scientist who was the former top partner of Hwang Woo-suk and a member of the research team that fabricated its embryonic stem cell research is pressing for the U.S. government to approve a patient he's applied for on human cloning.

University of Pittsburgh researcher Gerald Schatten wants to patent the process of cloning human embryos and embryonic stem cells without crediting his former research partners.

Hwang's team made two key claims -- that it had successfully cloned human embryos and that it had successfully cloned patient-specific embryonic stem cells that could overcome rejection issues.

The latter claim has proven false and Seoul National University is preparing to release the results of its investigation into the former.

Still, Schatten is pressing ahead and his application at the U.S. Patent &Trademark Office, which he filed in April 2004, is still pending.

According to a Pittsburgh Tribune Review article, Schatten and fellow scientists Calvin Simerly and Christopher Navara say their methods could make human cloning "a practical procedure," the application says. The methods could also be used to create embryonic stem cells.

Schatten was a co-author of the Science paper Hwang's team authored that has now been revoked and he has also come under investigation from Pitt.

Neither Pitt nor Schatten would respond to the Pittsburgh newspaper for comment on the patent application. Simerly and Navara also declined comment, the Tribune Review reported.

Merrill Goozman, of the Center for Science in the Public Interest, a watchdog group, told the Pittsburgh newspaper that the methods Schatten used to help Hwang's team engage in human cloning were funded in part by the National Institutes of Health to the tune of $1.8 million.

"I think that it is outrageous that the University of Pittsburgh refuses to discuss its patent claims on a technology that was funded by the U.S. taxpayers," he said in response.

The patent request could spark international controversy. Hwang insists that the human embryo cloning process works despite the falsified data and he insists the rights to it belong to the South Korean team. The team filed for an international patent in December 2004 and Schatten is not listed on that patient, the Tribune Review indicated.
187228
̵̧ : 1
°Ô½Ã±ÛÀ» twitter·Î º¸³»±â °Ô½Ã±ÛÀ» facebookÀ¸·Î º¸³»±â °Ô½Ã±ÛÀ» Me2Day·Î º¸³»±â °Ô½Ã±ÛÀ» ¿äÁòÀ¸·Î º¸³»±â °Ô½Ã±ÛÀ» ±¸±Û·Î ºÏ¸¶Å© Çϱ⠰ԽñÛÀ» ³×À̹ö·Î ºÏ¸¶Å© Çϱâ
ºÎÁ¤ºÎÆÐÃß¹æ½Ã¹Î¿¬ÇÕȸ(ºÎÃß¿¬)

 
 
 

Total 266,531
ÈÄ¿ø°èÁ : ³óÇù 301-0064-5221-51 (¿¹±ÝÁÖ : ºÎÁ¤ºÎÆÐÃß¹æ½Ã¹Î¿¬ÇÕȸ)
ºÎÃß¿¬ Á¦   ¸ñ ÀÛ¼ºÀÚ       ÀÛ¼ºÀÏ Á¶È¸ Ãßõ
77711    Á» ´õ ÀÚ¼¼È÷ ¾²¼ÌÀ¸¸é... ºÎÃß¿¬ 06-22 673 0
77710    »õ´©¸®¿¡ ħÅõÇÑ Á»¡¼¼·ÂÀÌ´Ù.º¸¼öÁ¤´çÀ» Á» ¸Ô´Â ÁÂÀͼ¼·ÂÀÌ´Ù. Çѱ¹ÀÎ 06-28 673 2
77709 [¹Ý±â¹® ´ë¸Á·Ð] »õ·Î¿î Ãæ°Ýº¯¼ö Á¤Ä¡¾ê±â 07-09 673 1
77708    ºÎÃß¿¬ ¾î¹öÀÌ¿¬ÇÕ ÀϺ£ ÇØÃ¼½ÃÄѾßÇÑ´Ù.. µÆ³ª? 07-11 673 1
77707 ´Þ°¿ ¹°º´ ´øÁø »ç¶÷µé »çÁø ´Ù ÂïÇûÀ½ ´Þ°¿ 07-16 673 3
77706 Çö´ë°Ç¼³ »ç±âºÐ¾ç, ´ë¹ý¿ø È®Á¤ ÆÇ°á ±è±â¼ö 07-20 673 1
77705 ÅëÀÏÁöµµÀÚ¾ÆÄ«µ¥¹Ì ÃÊ´ëÀå ¹è¹®Å 07-24 673 1
77704 °³¹«¼ºÀÌ Á×ÀÌ´À¶ó ´ëÇѹα¹ Á¤¸» °í»ýÇß´Ù. °³¹«¼º 08-12 673 2
77703 ºÏ¿¡¼­ °Ý¾îº» 8.15 ÇØ¹æÀý À̹κ¹ 08-17 673 1
77702 ¿ì¸® ³ª¶ó´Â ¾Ö±¹°¡¸¦ ºÎ¸£´Â ÇÑ ¸ÁÇÏÁö ¾Ê´Â´Ù Á¤Ã¢È­ 08-19 673 3
77701 ¿ª´ë ´ëÅë·É Áß¿¡¼­ °¡Àå û·ÅÇÑ ´ëÅë·É ÃÖ°í 08-27 673 4
77700 ±è´ëÁß Á¤±ÇÀÌ Á¶Æó°ø»ç¿¡¼­ ±Øºñ·Î µ· Âï¾î °¥¶ó¸Ô¾ú´Ù! (Æß) ¹Ì°¡¿¤ 09-01 673 6
77699 ¹Ú±ÙÇý´Â, ·¹ÀÓ´öÀÔ´Ï´Ù. Á¶¼øÇÏ 08-24 673 2
77698    °¨¿Á¿¡¼­ ´Ü½Ä ÅõÀïÇØ¶ó (1) ¾Ö±¹º¸¼ö 08-24 673 1
77697 À¯¼­ ³»¿ëÀÌ ·Ôµ¥Àϰ¡ Âù¾çÀÏ»öÀ̳×~~ Á¾»¡ 08-30 673 1
77696 Á¶¼±ÀϺ¸´Â ±Ç·Â±â°üÀΰ¡? ¾ð·ÐÀΰ¡? 092 08-24 673 1
77695 ¹Ú¿ø¼ø °ËÂû¿¡ °í¹ßÇØ¾ß. Å«ÄÚ 09-06 673 2
77694 ¿ë°¨ÇÑ µ¿¾ÆÀϺ¸ ³í¼³À§¿ø µ¶ÀÚ 09-07 673 1
77693 ´ëÅë·ÉÀÌ ´©°¡µÇ°Ç °ü½É¾ø¾î. ¼Õ»ç·¡ 09-19 673 2
77692 ¹ÚÁö¿ø ÄÚ¸Þµð ÄÚ¸Þµð 09-28 673 1
   9441  9442  9443  9444  9445  9446  9447  9448  9449  9450    
´Á´ë´åÄÄ
¿ì) 06233 ¼­¿ï °­³²±¸ °­³²´ë·Î 84±æ 23 ÇѶóŬ·¡½Ä 1115È£ TEL : 02-558-5544 FAX : 02-566-6266
[E-mail] [email protected]
ºÎÁ¤ºÎÆÐÃß¹æ½Ã¹Î¿¬ÇÕȸ / °íÀ¯¹øÈ£Áõ 220-82-60326 / °³ÀÎÁ¤º¸°ü¸®ÀÚ À±¿ë
ÈÄ¿ø°èÁ : ³óÇù 301-0064-5221-51 (¿¹±ÝÁÖ : ºÎÃß¿¬ TV)
ÀÎÅÍ³Ý ÁÖ¼Ò : badkiller.kr
Korean Solidarity for Anti-Corruption Copyrights 2000 All Rights Reserved